Anixa Biosciences And 2 Other Penny Stocks Worth Watching

Over the past 7 days, the U.S. market has experienced a slight drop of 1.5%, although it remains up by 12% over the last year with earnings forecasted to grow by 18% annually. In light of these conditions, identifying stocks with strong fundamentals and growth potential is crucial for investors looking to capitalize on market opportunities. Penny stocks, often representing smaller or newer companies, continue to offer intriguing prospects for those seeking hidden value at lower price points without necessarily taking on excessive risk.

Below we spotlight a couple of our favorites from our exclusive screener.

Anixa Biosciences (ANIX)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Anixa Biosciences, Inc. is a biotechnology company that develops therapies and vaccines targeting critical unmet needs in oncology, with a market cap of $96.99 million.

Operations: Anixa Biosciences, Inc. currently does not report any revenue segments.

Market Cap: $96.99M

Anixa Biosciences, Inc., with a market cap of US$96.99 million, remains pre-revenue as it focuses on developing innovative cancer therapies and vaccines. Despite being unprofitable, Anixa has reduced its losses by 5% annually over the past five years and maintains a stable cash runway exceeding one year. The recent addition of Dr. Carmen Guerra to its advisory board enhances its expertise in cancer screening and clinical trials. Anixa's patent portfolio continues to expand internationally with promising developments in breast cancer vaccine technology, supporting ongoing clinical trials for ovarian cancer therapies without observed dose-limiting toxicities so far.

• Take a closer look at Anixa Biosciences' potential here in our financial health report.
• Evaluate Anixa Biosciences' prospects by accessing our earnings growth report.

Plutus Financial Group (PLUT)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Plutus Financial Group Limited, with a market cap of $32.39 million, operates in Hong Kong offering financial services through its subsidiaries.

Operations: The company's revenue is primarily derived from its Securities Related Services (HK$3.97 million), Asset Management Services (HK$3.74 million), and Money Lending Segment (HK$2.73 million).

Market Cap: $32.39M

Plutus Financial Group, with a market cap of $32.39 million, operates in Hong Kong and is currently unprofitable. The company generates limited revenue (HK$9M) across its securities-related services, asset management, and money lending segments. Despite being debt-free and having short-term assets exceeding liabilities (HK$111.1M vs HK$32.2M), Plutus faces challenges with less than a year of cash runway and high share price volatility over the past three months. The board's average tenure is 1.6 years, indicating a relatively inexperienced team guiding the company through its financial hurdles amidst declining earnings over recent years.

• Unlock comprehensive insights into our analysis of Plutus Financial Group stock in this financial health report.
• Evaluate Plutus Financial Group's historical performance by accessing our past performance report.

AmeriServ Financial (ASRV)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: AmeriServ Financial, Inc. is a bank holding company for AmeriServ Financial Bank, offering consumer, mortgage, and commercial financial products in the United States with a market cap of $78.10 million.

Operations: The company generates revenue of $60.40 million from its community banking operations.

Market Cap: $78.1M

AmeriServ Financial, with a market cap of US$78.10 million, shows potential in the penny stock arena due to its stable financial performance and strategic management. The company reported net income growth to US$2.74 million for Q2 2026, reversing a loss from the previous year, and earnings per share improved significantly alongside increased net interest income. Despite a low return on equity of 6.9%, AmeriServ benefits from primarily low-risk funding through customer deposits and maintains an appropriate loans-to-assets ratio of 69%. Its seasoned management team supports sustainable operations while offering reliable dividends at 2.54%.

• Click to explore a detailed breakdown of our findings in AmeriServ Financial's financial health report.
• Gain insights into AmeriServ Financial's past trends and performance with our report on the company's historical track record.

Make It Happen

• Unlock our comprehensive list of 330 US Penny Stocks by clicking here.
• Want To Explore Some Alternatives? Rare earth metals are the new gold rush. Find out which 35 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com